Search

everythinglearnresearchcommunity

for

Search:↓

Different types of hair loss can be caused by hormones, stress, autoimmune disorders, illness, or nutritional deficiencies, and can be treated with medication, nutritional supplements, or hair transplantation.

Biotin treatment for hair, nail, and skin disorders has weak evidence and should not be recommended unless new research shows clear benefits.

The document concludes that scalp conditions have various causes and can present in many different ways.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Children's skin diseases need special care and treatment.

Certain genes are linked to the risk of developing Alopecia Areata.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Minoxidil can help regrow hair in alopecia areata patients.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

The laser comb did not improve hair regrowth in mice with alopecia areata.

Fractional laser therapy may help regrow hair in alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

JAK inhibitors show promise as a future treatment for hair loss.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.